by Maria Zannes | May 3, 2017 | Press Releases
MAY 3, 2017 (SAN ANTONIO, TX ) bioAffinity Technologies announced that the European Patent Office (EPO) has issued a patent that protects the Company’s proprietary CyPath® technology for the early detection of lung cancer through 2030. The EPO patent, titled “System...
by Maria Zannes | Apr 20, 2017 | News
APRIL 20, 2017 As published in the San Antonio Business Journal By W. Scott Bailey bioAffinity Technologies Inc. has found its groove since moving from New Mexico to San Antonio in March 2014. Steven Girgenti, executive chairman of bioAffinity, attributes that...
by Maria Zannes | Mar 9, 2017 | News
MARCH 9, 2017 (SAN ANTONIO, TX) The San Antonio City Council today authorized the San Antonio Economic Development Corporation (SAEDC) to invest in locally based bioAffinity Technologies, a biotech company focused on the significant unmet need for non-invasive, early-...
by Maria Zannes | Nov 15, 2016 | Press Releases
NOVEMBER 15, 2016 (SAN ANTONIO, TX) bioAffinity Technologies announced that the government of the Hong Kong Special Administrative Region has awarded a Certificate of Grant of Standard Patent for the Company’s proprietary CyPath© technology for the early detection of...
by Maria Zannes | Aug 25, 2016 | Articles, News
AUGUST 25, 2016 As published in the San Antonio Business Journal By W. Scott Bailey City Council authorized the San Antonio Economic Development Corporation on Thursday to directly invest in bioAffinity Technologies. It’s another indication that City Hall is...
